Abstract
Gastroesophageal reflux disease (GERD) is one of the most common digestive pathologies. It is a chronic condition caused by the reflux of gastric contents into the esophagus and causes the appearance of symptoms sometimes associated with lesions of the esophageal mucosa. The main cause of gastroesophageal reflux is insufficient contraction of the lower esophageal sphincter and its pathological relaxation. A wide variety of pathologies (hiatal hernia, obesity), conditions (pregnancy), foods (chocolate, high-fat foods, carbonated drinks, coffee), and drugs (estrogens, progesterone, theophylline, antidepressants) can contribute to the occurrence of reflux esophagitis. Therapeutic management can sometimes be difficult. In the current therapeutic arsenal, the most used therapy is that with proton pump inhibitors (PPIs). In cases with severe symptoms, even surgical treatment can be resorted to. Esophagitis from GERD must be differentiated from esophagitis associated with other etiologies such as eosinophilic esophagitis, infectious, drug induces, Esophagitis dissecans superficialis or necrotizing esophagitis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
El-Serag H. The association between obesity and GERD: a review of the epidemiological evidence. Dig Dis Sci. 2008;53:2307–12.
Moayyedi P, Talley NJ. Gastro-oesophageal reflux disease. Lancet. 2006;367:2086–100.
Chen SL, Gwee KA, Lee JS, Miwa H, Suzuki H, Guo P, et al. Systematic review with metaanalysis: prompt endoscopy as the initial management strategy for uninvestigated dyspepsia in Asia. Aliment Pharmacol Ther. 2015;41:239–52.
Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut. 1999;45:172–80.
Person E, Rife C, Freeman J, Clark A, Castell DO. A novel sleep positioning device reduces gastroesophageal reflux: a randomized controlled trial. J Clin Gastroenterol. 2015;49:655–9.
Weijenborg PW, Cremonini F, Smout AJPM, Bredenoord AJ. PPI therapy is equally effective in well-defined non-erosive reflux disease and in reflux esophagitis: a meta-analysis. Neurogastroenterol Motil. 2012;24:747–57.
Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013;108:308–28.
Sandhu DS, Fass R. Current trends in the management of gastroesophageal reflux disease. Gut Liver. 2018;12:7–16.
Hirano I, Chan ES, Rank MA, Sharaf RN, Stollman NH, Stukus DR, et al. AGA Institute and the joint task force on allergy-immunology practice parameters clinical guidelines for the Management of Eosinophilic Esophagitis. Gastroenterology. 2020;158:1776–86.
Săftoiu A, Cazacu S, Kruse A, Georgescu C, Comănescu V, Ciurea T. Acute esophageal necrosis associated with alcoholic hepatitis: is it black or is it white? Endoscopy. 2005;37:268–71.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Popa, P. (2023). Gastroesophageal Reflux Disease and Esophagitis. In: Săftoiu, A. (eds) Pocket Guide to Advanced Endoscopy in Gastroenterology. Springer, Cham. https://doi.org/10.1007/978-3-031-42076-4_21
Download citation
DOI: https://doi.org/10.1007/978-3-031-42076-4_21
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-42075-7
Online ISBN: 978-3-031-42076-4
eBook Packages: MedicineMedicine (R0)